Venture Capital

Oasys: $4.6 Million Raised To Build An AI-Native Operating System For Behavioral Health

By Amit Chowdhry ● Yesterday at 3:21 PM

Oasys Health, which is known as an AI-native operating system for behavioral health, raised $4.6 million in funding to expand its platform that combines practice management, clinical decision support, and real-time physiological data from consumer wearables. The financing includes a $4 million seed round led by Pathlight Ventures with participation from Twine Ventures and Better Ventures, plus $600,000 in pre-seed funding from 1984 Ventures.

Spearmint Energy Lands Kyuden Equity Investment For Two 200 MWh ERCOT Battery Projects

By Amit Chowdhry ● Yesterday at 3:18 PM

Spearmint Energy closed an equity investment from Kyuden International Corporation to support Tierra Seca and Seven Flags, two 100 MW / 200 MWh battery energy storage systems (BESS) located in Del Rio and Laredo, Texas. The two projects add a combined 400 MWh of storage capacity to ERCOT, the Texas power grid.

Faropoint Secures $600 Million Acquisition Credit Facility For Industrial Value Fund IV

By Amit Chowdhry ● Yesterday at 10:54 AM

Faropoint has secured a $600 million acquisition credit facility to support its Industrial Value Fund IV, a vehicle focused on acquiring and upgrading last-mile urban logistics properties across key U.S. markets.

Vauban Infrastructure Partners Names Olivier Guerrini Investment Director

By Amit Chowdhry ● Yesterday at 10:20 AM

Vauban Infrastructure Partners said it has appointed Olivier Guerrini as Investment Director, effective January 2026, adding an energy transition executive with more than two decades of experience across utilities and independent power producers to the firm’s investment platform.

Lux: $1.5 Billion For Lux Ventures IX Closed

By Amit Chowdhry ● Yesterday at 10:16 AM

Lux, a venture capital firm focused on investing at the frontier of science and technology, announced the close of Lux Ventures IX, a $1.5 billion fund the firm described as its largest to date.

Spiro Medical: $67 Million Series Raised A To Develop Neuromodulation System For Asthma

By Amit Chowdhry ● Yesterday at 10:00 AM

Spiro Medical, a newly formed company focused on pulmonary neuromodulation for asthma, has closed a $67 million Series A equity financing to develop what it describes as a first-of-its-kind Pulmonary Neuromodulation System (PNM) for the treatment of asthma.

STRM.BIO: $8 Million Series Seed 2 Closed To Advance Non-Viral Gene Delivery For In Vivo Cell Engineering And Gene Therapy

By Amit Chowdhry ● Yesterday at 9:57 AM

STRM.BIO raised $8 million in a Series Seed 2 financing to advance its non-viral gene delivery platform for in vivo cell engineering and gene therapy. The round included funding from Recordati, with continued participation from Boehringer Ingelheim Venture Fund and Delos Capital, plus new backing from Blue Bay Capital Fund; the Seed 2 round remains open with plans to close by Q1 2026.

Swap: $100 Million Series C Raised To Expand Global Commerce Platform

By Amit Chowdhry ● Yesterday at 9:55 AM

Swap has raised a $100 million Series C round co-led by DST Global and ICONIQ, with ICONIQ increasing its stake after leading the company’s $40 million Series B six months earlier. The New York-based startup positions itself as a “commerce operating system,” evolving from a returns-focused product into a broader platform spanning cross-border commerce, tax, and demand planning.

Luxury Presence: $37 Million Secured To Launch Presence CRM

By Amit Chowdhry ● Yesterday at 9:00 AM

Luxury Presence said it has raised $37 million in new financing to accelerate the rollout of Presence CRM, a product the company describes as the first “AI relationship engine” designed to help real estate agents identify deal opportunities already embedded in their networks.

Cyera: $400 Million Series F At $9 Billion Valuation Raised As Enterprises Ramp Up AI Security

By Amit Chowdhry ● Yesterday at 8:33 AM

Cyera, an AI and data security company, has raised $400 million in a Series F funding round led by funds managed by Blackstone, pushing the company’s valuation to $9 billion and bringing total funding to more than $1.7 billion. The financing comes roughly six months after Cyera’s prior round and marks a valuation that the company says has tripled over the past year.

ViCentra Expands Series D To $98 Million To Scale Kaleido Insulin Patch Pump Commercialization

By Amit Chowdhry ● Yesterday at 8:22 AM

ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, said it has added $13 million in new capital to its Series D financing, bringing the total round to $98 million. The second close includes new investments from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, as well as increased backing from existing investor Innovation Industries.

Sibros Raises $9 Million in Growth Financing

By Amit Chowdhry ● Yesterday at 7:43 AM

Sibros has raised $9 million in a growth financing round, with Niterra Co., Ltd. participating in the investment as the software-defined vehicle (SDV) platform provider looks to expand product capabilities and scale commercialization.

TECregen Raises CHF 10 Million Seed Round, Names Dr. Bo Rode Hansen Chairman

By Amit Chowdhry ● Yesterday at 7:42 AM

Basel, Switzerland-based TECregen has raised CHF 10 million (approximately €10.7 million / $12.6 million) in seed financing to advance a new class of thymus-rejuvenating biologics aimed at restoring immune function by rejuvenating thymic epithelial cells (TECs). The round was led by the Boehringer Ingelheim Venture Fund (BIVF) and included participation from LifeSpan Vision Ventures, Carma Fund, EOS BioInnovation, High-Tech Gründerfonds (HTGF), the JFG Life Sciences Foundation of the University of Basel, and Zurich Cantonal Bank.

Enable Injections Announces $30 Million Sanofi Investment To Expand enFuse On-Body Injector Manufacturing

By Amit Chowdhry ● Yesterday at 7:26 AM

Enable Injections announced that Sanofi is making a $30 million investment in the Cincinnati-based drug delivery company to accelerate a manufacturing build-out, bolster supply chain capabilities, and support commercial growth for its enFuse on-body delivery system.

Protege: $30 Million Raised To Expand Real-World Data Access For AI Development

By Amit Chowdhry ● Yesterday at 7:24 AM

Protege, an AI data platform focused on unlocking trusted, real-world datasets at scale, has raised a $30 million Series A round led by Andreessen Horowitz (a16z). The financing expands the company’s previously announced $25 million Series A from August 2025 and brings total funding to $65 million since Protege’s founding in 2024. Returning investors include Footwork, CRV, Bloomberg Beta, Flex Capital, Shaper Capital, and others.

Tenax Aerospace Completes Refinancing, Buys Out Bain Capital Credit And Consolidates NTC Group Ownership

By Amit Chowdhry ● Yesterday at 7:20 AM

Tenax Aerospace, a provider of special mission aircraft and related services to U.S. government and commercial customers, said it has completed a refinancing that includes the buyout of its junior capital partner, Bain Capital Credit, consolidating ownership of the business under NTC Group.

Parabilis Medicines: $305 Million Series F Raised To Advance Zolucatetide Program And Helicon Peptide Platform

By Amit Chowdhry ● Yesterday at 7:10 AM

Parabilis Medicines, a clinical-stage cancer drug developer, said it has closed an oversubscribed $305 million Series F financing to fund ongoing clinical development of its lead candidate FOG-001 (zolucatetide) across multiple tumor types and to expand a broader pipeline built on its Helicon peptide platform. The round was co-led by RA Capital Management, Fidelity Management & Research Company, and Janus Henderson Investors. Parabilis said new investors in the financing included Frazier Life Sciences, Soleus Capital, and a life science-dedicated investment fund, alongside participation from a broad syndicate of existing backers including venBio Partners, Cormorant Asset Management, ARCH Venture Partners, GV, accounts advised by T. Rowe Price Associates, Marshall Wace, General Catalyst, Invus, Farallon Capital Management, Foresite Capital, Rock Springs Capital, HBM Healthcare, Samsara BioCapital, Catalio Capital Management, and others.

NovaWave Capital Adds New Investors And Unveils Arizona “WaveX” AI Venture Studio With State Commerce Authority

By Amit Chowdhry ● Yesterday at 7:08 AM

NovaWave Capital announced it has reached a new milestone for its NovaWave Fund I generation, adding AZ Venture Capital Inc. and Sunny Day Sports as incoming investors, as it expands its public-private capital base to support innovation across the U.S.